Clinical Trial Update: Rosiglitazone in Treating Patients With Liposarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rosiglitazone in patients with liposarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Sarcoma | Phase 2 | Status: COMPLETED